Lercanidipine clinical trials
How each study uses lercanidipine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the lercanidipine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 3
Lee's Pharmaceutical Limited (2) · LG Life Sciences (2) · Aarhus University Hospital (1) · RECORDATI GROUP (1) · UCB Pharma (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · University of Aarhus (1)
Often tested with
Tested in the same studies.
Valsartan (2) · Hydrochlorothiazide (2) · Clopidogrel (1) · Amlodipine (1) · Ramipril (1) · Losartan (1) · Enalapril (1) · Spironolactone (1)
Related medicines
As reviewed, each with the page that says it.
- One of Calcium channel blockers source
Studies
Open first, then newest update. How each study uses lercanidipine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- The Role of Skin Sodium Accumulation in Chronic Kidney DiseaseRecruitingNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT07020104Written as LercanidipineHow we know
- Zainidip in Renal Artery StenosisCompletedPhase 4Lee's Pharmaceutical LimitedNCT02594410Written as LercanidipineHow we know
- Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for HypertensionCompletedPhase 4Lee's Pharmaceutical LimitedNCT01520285Written as ZanidipHow we know
- Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive PatientsCompletedPhase 3LG Life SciencesNCT01928628Written as Lercanidipine 10mgHow we know
- Intensive Vasodilator Therapy in Patients With Essential HypertensionCompletedPhase 4Aarhus University HospitalNCT01180413Written as LercanidipineHow we know
- Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential HypertensionCompletedPhase 2RECORDATI GROUPNCT01093807Written as LercanidipineHow we know
- Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential HypertensionCompletedPhase 2LG Life SciencesNCT01122251Written as Lercanidipine + ValsartanHow we know
- Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina PectorisTerminatedNot applicableUniversity of AarhusNCT00424801Written as LercanidipineHow we know
- Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese PatientsCompletedNot applicableUCB PharmaNCT00160498Written as LercanidipineHow we know
As the comparator · 1 — what is tested is compared with lercanidipine
Codes
What other systems call lercanidipine · ClinicalTrials.gg INT003449
- MeSH (NLM) C060343lercanidipineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) V7XTJ4R0BHLERCANIDIPINEConfirmed FDA, NLM, Wikidata
- RxNorm 135056Confirmed FDA, Wikidata
- Wikidata Q410492lercanidipineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81687LercanidipineOne source FDA
- DrugBank DB00528One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C060343 | lercanidipine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | V7XTJ4R0BH | LERCANIDIPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 135056 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410492 | lercanidipine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81687 | Lercanidipine | One source FDA |
| DrugBank | DB00528 | — | One source Wikidata |
Also registered as lercanidipine hydrochloride (UNII OA8TFX68PE · RxNorm 153679).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.